![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis
This randomized clinical trial examines the efficacy of high-dose cholecalciferol (vitamin D) as monotherapy in reducing disease activity in patients with clinically isolated syndrome typical of multiple sclerosis.
This randomized clinical trial examines the efficacy of high-dose cholecalciferol (vitamin D) as monotherapy in reducing disease activity in patients with clinically isolated syndrome typical of multiple sclerosis.
